BlackRock, Inc.

Holdings History for Cytek Biosciences, Inc. - Common Stock - $0.001 par value (CTKB)

Symbol: CTKB on Nasdaq
Investment type: Equity / Common Stock - $0.001 par value
Latest Disclosed Shares Owned: 16,531,858 shares
Security Ownership %: 13%

Shares, Excluding Options vs Price

Value, Excluding Options

BlackRock, Inc. ownership in Cytek Biosciences, Inc. Common Stock - $0.001 par value (CTKB)

18 Jul 2025 - BlackRock, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 16,531,858 shares of Cytek Biosciences, Inc. Common Stock - $0.001 par value (CTKB). This represents 13% ownership of the company. In their previous filing dated 05 Feb 2025, BlackRock, Inc. had reported owning 18,482,795 shares, indicating a decrease of +11%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
BlackRock, Inc.	13%	-8.6%	$62,325,105	16,531,858	-1,950,937	-11%	$3.77	13G/A	30 Jun 2025	18 Jul 2025, 14:52
BlackRock, Inc.	14%		$67,831,858	18,482,795			$3.67	13G/A	31 Dec 2024	05 Feb 2025, 13:23

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025	0%	-0%	$57,420,495	16,547,693	-487,842	-2.9%	$3.47	Q3 2025
30 Jun 2025	0%	-0%	$57,920,818	17,035,535	-1,033,747	-5.7%	$3.40	Q2 2025
31 Mar 2025	0%	-0%	$72,457,819	18,069,282	-413,513		$4.01	Q1 2025
31 Dec 2024	0%	-0%	$119,953,341	18,482,795	-9,496	-0.05%	$6.49	Q4 2024
30 Sep 2024	0%	0%	$102,447,292	18,492,291	0		$5.54	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.